【丽珠医药早盘股价上涨 3.29%,现报 28.30 港元,成交额 3276.52 万港元】2025 年 5 月 22 日,丽珠医药间接全资附属 LIANSG HOLDING PTE.LTD.拟向 SK Investment、Sunrise 及 KBA 收购 Imexpharm Corporation 已发行股份的 64.81%,总现金代价约为人民币 15.87 亿元,港币 17.28 亿元。 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.